InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | 2026-05-18 | Sastry Ann Marie | Director & CHIEF EXECUTIVE OFFICER | Purchase | 174.2K | $1.44 | $250K | 1.05M | View ↗ | |
| 2026-04-28 | 2026-05-18 | Parmer George | Director | Purchase | 243.9K | $1.44 | $350K | 567.0K | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Revenue | $110K-33.8% | $167K-80.3% | $845K+21.2% | $697K+3.3% | $675K |
| General and administrative expenses | $2.5M-14.8% | $2.9M+16.7% | $2.5M-51.9% | $5.2M+12.2% | $4.6M |
| Technology and content development | $691K-35.7% | $1.1M-29.5% | $1.5M-50.2% | $3.1M+34.4% | $2.3M |
| Sales and marketing expenses | $545K-28.7% | $764K-27.5% | $1.1M-30.2% | $1.5M-13.8% | $1.8M |
| Total operating expenses | $3.7M-21.8% | $4.7M-6.4% | $5.1M-48.0% | $9.8M+12.8% | $8.6M |
| Loss from Operations | -$3.6M+21.3% | -$4.6M-8.4% | -$4.2M+53.4% | -$9.1M | — |
| Interest income | $77K-56.1% | $176K+142.3% | $73K | — | — |
| Impairment expense (Note 3) | -$91K | — | — | — | — |
| Total other income | -$13K-107.6% | $176K+147.8% | $71K | — | — |
| Net Loss | -$3.6M+17.9% | -$4.4M-6.0% | -$4.2M+54.2% | -$9.1M+21.8% | -$11.6M |
| Basic loss per share (in Dollars per share) | -$1.03+40.5% | -$1.73-3.0% | -$1.68+64.0% | -$4.67-691.5% | -$0.59 |
| Diluted loss per share (in Dollars per share) | -$1.03+40.5% | -$1.73 | — | — | — |
| Weighted average shares outstanding (in Shares) | $3.5M+38.7% | $2.5M+2.9% | $2.5M+27.4% | $1.9M-90.1% | $19.5M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Amesite Stock Soars 150% on New Enterprise Deal. What to Know.
Amesite Rips 250% On Its Largest AI Healthcare Deployment
Amesite shares skyrocket after landing largest enterprise client to date (AMST)
Amesite shares surge 250% on milestone enterprise contract for NurseMagic AI